Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Arthritis Research & Therapy|December 26, 2015
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trialsDinesh Khanna, Vivek Nagaraja, Chi-Hong Tseng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Celecoxib decreases Ki-67 proliferative index in active smokersJenny T Mao, Michael C Fishbein, Bradley Adams, et al.AIDS Research and Human Retroviruses|December 26, 2008
Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual menChun Chao, Lisa P Jacobson, Frank J Jenkins, et al.Arthritis Research & Therapy|January 1, 2017
Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung diseaseElizabeth R Volkmann, Donald P Tashkin, Michael D Roth, et al.Thorax|April 10, 2025
Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohortsScott M Matson, Grace Hyun J Kim, Stephen M Humphries, et al.Journal of Clinical Pharmacology|December 21, 2007
Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patientsJosephia R Muindi, Michael D Roth, Robert A Wise, et al.American Journal of Respiratory and Critical Care Medicine|March 5, 2002
A pilot study of all-trans-retinoic acid for the treatment of human emphysemaJenny T Mao, Jonathan G Goldin, John Dermand, et al.Arthritis and Rheumatism|May 7, 2011
Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung diseaseMichael D Roth, Chi-Hong Tseng, Philip J Clements, et al.Arthritis and Rheumatism|May 28, 2011
Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo GroupDinesh Khanna, Chi-Hong Tseng, Niloofar Farmani, et al.Arthritis & Rheumatology (Hoboken, N.J.)|April 5, 2017
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and IIElizabeth R Volkmann, Donald P Tashkin, Ning Li, et al.Pageof 10